RT Journal Article SR Electronic T1 Molecular Imaging of Immunotherapy Targets in Cancer JF Journal of Nuclear Medicine JO J Nucl Med FD Society of Nuclear Medicine SP 1487 OP 1492 DO 10.2967/jnumed.116.177493 VO 57 IS 10 A1 Emily B. Ehlerding A1 Christopher G. England A1 Douglas G. McNeel A1 Weibo Cai YR 2016 UL http://jnm.snmjournals.org/content/57/10/1487.abstract AB Immunotherapy has emerged as a promising alternative in the arsenal against cancer by harnessing the power of the immune system to specifically target malignant tissues. As the field of immunotherapy continues to expand, researchers will require newer methods for studying the interactions between the immune system, tumor cells, and immunotherapy agents. Recently, several noninvasive imaging strategies have been used to map the biodistribution of immune checkpoint molecules, monitor the efficacy and potential toxicities of the treatments, and identify patients who are likely to benefit from immunotherapies. In this review, we outline the current applications of noninvasive techniques for the preclinical imaging of immunotherapy targets and suggest future pathways for molecular imaging to contribute to this developing field.